Drugs / Enterovirus type EV71 vaccine (Vero cell), Inactivated
Enterovirus type EV71 vaccine (Vero cell), Inactivated
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06063057 Comparator | Sep 2023 → Dec 2025 | hand, foot and mouth disease, herpangina | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enterovirus type EV71 vaccine (Vero cell), Inactivated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06063057 ↗ |
| Modality | Vaccine | “Enterovirus type EV71 vaccine (Vero cell), Inactivated” NCT06063057 ↗ |